Format

Send to

Choose Destination
See comment in PubMed Commons below
J Surg Oncol. 2013 May;107(6):665-72. doi: 10.1002/jso.23295. Epub 2012 Nov 28.

Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.

Author information

1
Division of Breast/Soft Tissue and Endocrine Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.

Abstract

Post-operative management of differentiated thyroid cancer (DTC) often involves administration of radioactive iodine (RAI) for remnant ablation or adjuvant therapy. However, given the favorable prognosis associated with DTC, the risk versus benefit ratio of RAI remains unclear. RAI is associated with substantial, albeit rare side effects, including a possible increased risk of secondary malignancy and altered fertility, which must be balanced against the magnitude of benefit for decreasing recurrence and improving survival.

PMID:
23192391
DOI:
10.1002/jso.23295
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center